QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 28, no. 3 (2009): 827-834
doi: 10.1377/hlthaff.28.3.827
© 2009 by Project HOPE
 
New Online
 * Senate Health Reform Bill
 * Rewarding Providers
 * Public Option Policy Brief
 * Health Reform & Abortion
 * Delivery System Reform
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Choudhry, N. K.
* Articles by Shrank, W. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Choudhry, N. K.
* Articles by Shrank, W. H.
Related Collections
* Access To Care
* Legal/Regulatory Issues
* Business Of Health
* Pharmaceuticals
* Chronic Care
* Health Spending
* Consumer Issues

Health Tracking

MARKETWATCH

Drug Company–Sponsored Patient Assistance Programs: A Viable Safety Net?

Niteesh K. Choudhry, Joy L. Lee, Jessica Agnew-Blais, Colleen Corcoran and William H. Shrank

Drug company–sponsored patient assistance programs (PAPs) provide access to brand-name medications at little or no cost and have been advocated as a safety net for inadequately insured patients. Yet little is known about these programs. We surveyed drug company–sponsored PAPs and found much variability in their structures and application processes. Most cover one or two drugs. Only 4 percent disclosed how many patients they had directly helped, and half would not disclose their income eligibility criteria. A better understanding of PAPs might clarify their role in improving access to medications, the adequacy of existing public programs, and their impact on cost-effective medication use.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
K. Johnson
Voluntary Patient Assistance Programs: Additional Federal Oversight Unwarranted
Health Aff., May 1, 2009; 28(3): 835 - 838.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
M. Weinberg
Reforming Patient Assistance Programs: Perfect World Meets Real World
Health Aff., May 1, 2009; 28(3): 839 - 842.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2009 Project HOPE–The People-to-People Organization
Terms and Policies